all 3 comments

[–]i_cansmellthat 2 insightful - 1 funny2 insightful - 0 funny3 insightful - 1 funny -  (0 children)

"In turn, the U.S. Food and Drug Administration is asking "interested persons" to submit comments that can inform the country's position on the issue before it weighs in with the UN. Specifically, FDA is inviting input on the "abuse potential, actual abuse, medical usefulness, trafficking and impact of scheduling changes on availability for medical use of" cannabis and its compounds, the agency wrote in a Federal Register notice scheduled to be published on Monday."

Curious to see what qualifies as "interested persons" and how they are permitted to comment.

[–]magnora7[A] 1 insightful - 1 funny1 insightful - 0 funny2 insightful - 1 funny -  (0 children)

This has been selected as saidit's post of the day and is an announcement stickied at the top of the sub for the next 24 hours.

[–]i_cansmellthat 1 insightful - 1 funny1 insightful - 0 funny2 insightful - 1 funny -  (0 children)

I wonder if the possible reclassification would have anything to do with this: GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex® (cannabidiol) Patents

As a schedule one drug, marijuana is in the category of having no accepted medical use, and a patent for medical cannaboid compounds may be a conflict.